Gene‐ and pathway‐level analyses of <scp>iCOGS</scp> variants highlight novel signaling pathways underlying familial breast cancer susceptibility
Christine Lonjou(Inserm), Fabienne Lesueur(Inserm), Laurence Gladieff(Institut Claudius Regaud), Francesca Damiola(Centre Léon Bérard), Maria Kondratova(Inserm), Mojgan Karimi(Inserm), Juana Beauvallet(Inserm), Paul Gesta(Centre Hospitalier de Niort), Marie‐Gabrielle Dondon(Inserm), Noura Mebirouk(Inserm), Isabelle Mortemousque(Centre Hospitalier Universitaire de Tours), Thierry Frébourg(Inserm), Sophie Lejeune‐Dumoulin(Centre Hospitalier Universitaire de Lille), Eve Cavaciuti(Inserm), Séverine Audebert‐Bellanger(Centre Hospitalier Régional Universitaire de Brest), Thérèse Truong(Université Paris-Sud), Inna Kuperstein(Inserm), Pascal Guénel(Inserm), Capucine Delnatte(Laboratoire de Génétique Cellulaire), Laure Barjhoux(Centre Léon Bérard), Laurence Venat‐Bouvet(Hôpital Universitaire Dupuytren), Pascal Pujol(Centre National de la Recherche Scientifique), Séverine Eon‐Marchais(Inserm), Emmanuel Barillot(Inserm), Dorothée Le Gal(Inserm), Olivier Caron(Université Paris-Saclay), Yves‐Jean Bignon(Centre Jean Perrin), Alain Lortholary, Yue Jiao(Inserm), Dominique Stoppa‐Lyonnet(Centre National de la Recherche Scientifique), Nadine Andrieu(Inserm), Anne Floquet(Institut Bergonié), Bruno Buecher(Université Paris Sciences et Lettres), Pascaline Berthet(Centre François Baclesse), Sophie Giraud(Hospices Civils de Lyon), Hélène Dreyfus, Valérie Bonadona(Centre Léon Bérard), Christine M. Maugard, Isabelle Coupier(Inserm), Jean Chiésa(Université de Nîmes), Christine Lasset(Centre National de la Recherche Scientifique), Laurence Faivre(Centre Georges François Leclerc), Marion Gauthier‐Villars, Catherine Noguès(Inserm), Élisabeth Luporsi(Institut de Cancérologie de Lorraine), Jean‐Marc Limacher(Transgene (France)), Luis‐Cristobal Monraz(Inserm), Sylvie Mazoyer(Université Claude Bernard Lyon 1)
Cited by 6
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k